Status:
COMPLETED
Adult Intracranial Ependymoma
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Intracranial Ependymoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Adult intracranial ependymoma is a relatively rare brain tumour entity, accounting for 2-5% of all intracranial neoplasms. The pertinent prognostic factors as well as the pattern of recurrence remain ...
Eligibility Criteria
Inclusion
- Diagnosis later(posterior) than January, 1990
- Diagnosis previous to June, 2004
- Available postoperative MRI at the not dead patients during operating
- Diagnosis of EICA held(retained) after centralized second reading
- Absence of histories of radiotherapy and\\or chemotherapy for a brain damage
Exclusion
- Diagnosis previous to January, 1990
- Diagnosis later(posterior) than June, 2004 ·
- Diagnosis of EICA not held(retained) after centralized second reading
- Histories of radiotherapy and\\or chemotherapy for a brain damage
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT00920335
Start Date
March 1 2009
End Date
July 1 2013
Last Update
February 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France